Faga Daniel — SEC Form 4 filings
SEC reporting owner CIK 1673528. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-01-09 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 6 filings — 212,277 shares, $6,344,271 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 52.
- Largest priced transaction: sale of 145,940 shares @ $22.78 ($3,325,185) in ANAPTYSBIO, INC, filed 2024-03-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANAPTYSBIO, INC (ANAB) | President, CEO, Director | 11 | — | 16 legs · 212,277 sh · $6,344,271 | 37 |
| First Tracks Biotherapeutics, Inc. (TRAX) | President, CEO, Director | 4 | — | — | 15 |
Form 4 filings — Faga Daniel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 193,575 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 53,334 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 193,576 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 100,200 (derivative) @ $0 · Grant/award (A): 271,100 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4/A | ANAPTYSBIO, INC (ANAB) | Disposition to issuer (D): 11,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | ANAPTYSBIO, INC (ANAB) | Disposition to issuer (D): 11,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Disposition to issuer (D): 2,321 (derivative) @ $0 · Grant/award (A): 2,321 (derivative) @ $0 · Disposition to issuer (D): 9,200 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · +8 more | EDGAR |
| 2026-04-22 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 2,321 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · Grant/award (A): 194,900 (derivative) @ $0 · Grant/award (A): 379,620 (derivative) @ $0 · Grant/award (A): 305,500 (derivative) @ $0 · +5 more | EDGAR |
| 2026-03-27 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 34,300 · Sale (S): 510 @ $56.61 · Sale (S): 2,570 @ $57.91 · Sale (S): 3,662 @ $58.62 · Sale (S): 490 @ $59.62 · Sale (S): 550 @ $60.63 · +5 more | EDGAR |
| 2026-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 26,838 · Sale (S): 14,281 @ $44.71 · Option exercise (M): 26,838 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 17,850 · Sale (S): 9,202 @ $45.11 · Option exercise (M): 17,850 (derivative) @ $0 · Grant/award (A): 98,600 (derivative) @ $0 · Grant/award (A): 133,400 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 34,677 · Sale (S): 15,309 @ $43.26 · Option exercise (M): 34,677 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 34,678 · Tax withholding (F): 13,033 @ $14.60 · Option exercise (M): 17,850 · Tax withholding (F): 6,387 @ $15.30 · Option exercise (M): 34,678 (derivative) @ $0 · Option exercise (M): 17,850 (derivative) @ $0 · +2 more | EDGAR |
| 2024-07-24 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-03-26 | 4 | ANAPTYSBIO, INC (ANAB) | Sale (S): 145,940 @ $22.78 · Sale (S): 3,000 @ $21.42 · Tax withholding (F): 347,441 @ $21.60 | EDGAR |
| 2024-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 17,850 @ $0 · Sale (S): 6,866 @ $21.81 · Option exercise (M): 17,850 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1673528 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →